People who tried it
During the treatment I did not have any problems, neither significant pain nor bleeding. My urinary function gradually improved over the following months, in addition to which I also resumed normal sexual activity.
(N.B., Engineer, aged 50)
About Soractelite TPLATM
EchoLaser and TPLA technique: successful procedures and international guests in Verona
On July 25th, 2025, at the Verona University Hospital (AOUI Verona), Professor Alessandro Antonelli and his team successfully performed three treatments for benign prostatic hyperplasia (BPH) and one focal therapy for prostate cancer using the EchoLaser system with...
EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...
EchoLaser is now NMPA approved
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...

Are you a physician?
If you would like to have more technical and clinical information on the laser ablation treatment of Benign Prostatic Hyperplasia, visit the corporate website: http://www.elesta-echolaser.com/soractelite/